国际呼吸杂志
國際呼吸雜誌
국제호흡잡지
INTERNATIONAL JOURNAL OF RESPIRATION
2014年
18期
1361-1366
,共6页
刘杰%陈荣昌%钟南山%李时悦%顾莹莹%欧阳铭%曾庆思
劉傑%陳榮昌%鐘南山%李時悅%顧瑩瑩%歐暘銘%曾慶思
류걸%진영창%종남산%리시열%고형형%구양명%증경사
淋巴管肌瘤病%肺母细胞瘤
淋巴管肌瘤病%肺母細胞瘤
림파관기류병%폐모세포류
Lymphangiomyomatosis%Pneumoblastoma
目的 加强肺淋巴管肌瘤病(LAM)合并恶性肿瘤的临床、影像、病理特点的认识,提高对该病的早期认识和治疗水平.方法 分析2013年3月收治的1例肺LAM并肺母细胞瘤患者临床资料及诊治经过,并结合相关文献进行复习.截止至2014年2月,以“Lymphangiomyomatosis、cancer”为检索词,在PubMed检索系统进行检索,论著3篇,综述1篇;在万方数据库中以“淋巴管肌瘤病、恶性肿瘤”为检索词进行检索,病例报告1篇.结果 患者,女,37岁,慢性病程,主要症状为咳嗽、咯血、胸痛3个月,既往有“双肾错构瘤”史,曾行右肾错构瘤切除术,术后病理示血管平滑肌脂肪瘤,左肾未予处理.曾有“自发性气胸”病史.胸部高分辨率CT示右中下肺巨大肿块并纵隔淋巴结肿大,考虑恶性病变;肺LAM.血清血管内皮生长因子D为1 092.61 ng/L.免疫组化示CD56灶(+),Vim小细胞(+),Syn(+),CD99(+/-),组织改变考虑为肺母细胞瘤.复习国内外文献,尚无LAM合并肺母细胞瘤的病例报道.结论 近十年来,随着LAM分子发病机制的深入研究,LAM目前可定义为低度恶性转移性肿瘤.本例患者为LAM合并高度恶性肿瘤肺母细胞瘤,在国内外尚属首例报道.但究其机制,是LAM细胞癌变为肺母细胞瘤,或是二者同时存在,目前尚无定论.
目的 加彊肺淋巴管肌瘤病(LAM)閤併噁性腫瘤的臨床、影像、病理特點的認識,提高對該病的早期認識和治療水平.方法 分析2013年3月收治的1例肺LAM併肺母細胞瘤患者臨床資料及診治經過,併結閤相關文獻進行複習.截止至2014年2月,以“Lymphangiomyomatosis、cancer”為檢索詞,在PubMed檢索繫統進行檢索,論著3篇,綜述1篇;在萬方數據庫中以“淋巴管肌瘤病、噁性腫瘤”為檢索詞進行檢索,病例報告1篇.結果 患者,女,37歲,慢性病程,主要癥狀為咳嗽、咯血、胸痛3箇月,既往有“雙腎錯構瘤”史,曾行右腎錯構瘤切除術,術後病理示血管平滑肌脂肪瘤,左腎未予處理.曾有“自髮性氣胸”病史.胸部高分辨率CT示右中下肺巨大腫塊併縱隔淋巴結腫大,攷慮噁性病變;肺LAM.血清血管內皮生長因子D為1 092.61 ng/L.免疫組化示CD56竈(+),Vim小細胞(+),Syn(+),CD99(+/-),組織改變攷慮為肺母細胞瘤.複習國內外文獻,尚無LAM閤併肺母細胞瘤的病例報道.結論 近十年來,隨著LAM分子髮病機製的深入研究,LAM目前可定義為低度噁性轉移性腫瘤.本例患者為LAM閤併高度噁性腫瘤肺母細胞瘤,在國內外尚屬首例報道.但究其機製,是LAM細胞癌變為肺母細胞瘤,或是二者同時存在,目前尚無定論.
목적 가강폐림파관기류병(LAM)합병악성종류적림상、영상、병리특점적인식,제고대해병적조기인식화치료수평.방법 분석2013년3월수치적1례폐LAM병폐모세포류환자림상자료급진치경과,병결합상관문헌진행복습.절지지2014년2월,이“Lymphangiomyomatosis、cancer”위검색사,재PubMed검색계통진행검색,론저3편,종술1편;재만방수거고중이“림파관기류병、악성종류”위검색사진행검색,병례보고1편.결과 환자,녀,37세,만성병정,주요증상위해수、각혈、흉통3개월,기왕유“쌍신착구류”사,증행우신착구류절제술,술후병리시혈관평활기지방류,좌신미여처리.증유“자발성기흉”병사.흉부고분변솔CT시우중하폐거대종괴병종격림파결종대,고필악성병변;폐LAM.혈청혈관내피생장인자D위1 092.61 ng/L.면역조화시CD56조(+),Vim소세포(+),Syn(+),CD99(+/-),조직개변고필위폐모세포류.복습국내외문헌,상무LAM합병폐모세포류적병례보도.결론 근십년래,수착LAM분자발병궤제적심입연구,LAM목전가정의위저도악성전이성종류.본례환자위LAM합병고도악성종류폐모세포류,재국내외상속수례보도.단구기궤제,시LAM세포암변위폐모세포류,혹시이자동시존재,목전상무정론.
Objective To improve the recognition of clinical features,image,and pathology of pulmonary lymphangiomyomatosis (LAM) and pneumoblastoma and enhance treatment at early stage.Methods A patient with pulmonary LAM and pneumoblastoma was analyzed including clinical data,image and pathological features,and responses of treatment,who was admited in 2013 March.Three articles and one review were searched from January 1967 to February 2014 in PubMed database with "lymphangiomyomatosis,cancer" as the search terms.A case report was searched from January 1982 to February 2014 in Wanfang database.Results The main symptoms of this patient who was female and 37 years old were cough,hemoptysis,and chest pain for three months.Though she had hamartomas of bilateral kidney,she had ectomy of hamartoma of right kidney,and biopsy indicated angiomyolipoma.Spontaneous pneumothorax was occured in past.Chest high-resolution CT indicated right lung malignant disease and pulmonary LAM.The serum vascular endothelial growth factor-D concentration of this patient was 1092.61 ng/L.Lung biopsy confirmed as pneumoblastoma:immunohistochemisty CD56 (+),Vim (+),Syn(+),CD99(+/-).Through the review of literature,there was no case of LAM combined with pneumoblastoma reported.Conclusions In recent decade,LAM is defined as a low-grade,destructive,metastasizing neoplasm with the molecule pathogenetic development of LAM.The patient with LAM and pneumoblastoma was first reported in domestic and international literature.However,it is controversial and unclear whether it belongs to carcinomatous change of LAM cell or it originally includes two malignant neoplasms.